Results 221 to 230 of about 2,868,082 (296)

Silent refractoriness in epilepsy care: cross-sectoral analysis of prescribing patterns, referrals and workforce capacity in Saxony. [PDF]

Front Neurol
Mayer T, Lemke J, Von Podewils F, Scheid B, Kraya T, Hallmeyer-Elgner S, Classen J, Kostev K, Faber SC, Strzelczyk A.   +9 more
europepmc   +1 more source

Changing Case‐Mix and Inpatient Rehabilitation Costs in C4/C5 Traumatic Cervical Spinal Cord Injury: A 10‐Year Single‐Center Study From a National Rehabilitation Center in China

Chronic Diseases and Translational Medicine, EarlyView.
Trends in length of stay and inflation‐adjusted daily hospitalization cost in patients with C4/C5 TCSCI, China Rehabilitation Research Center, 2013–2022 (n = 1063). ABSTRACT Background The case‐mix and inpatient rehabilitation costs of traumatic cervical spinal cord injury (TCSCI) may have shifted with population aging and the coronavirus disease 2019 (
Juan Li, Wei Gao, Feng Yang, Xuan Gao, Yiming Zhang, Qing Wang, Lianjun Gao   +6 more
wiley   +1 more source

Video-Oculography-Based Detection of Skew Deviation in Patients Experiencing Dizziness in the Outpatient Setting: A Prospective Diagnostic Accuracy Study. [PDF]

Brain Sci
Chang TP, Lin HH, Bery AK.
europepmc   +1 more source

Copula‐based joint modelling of emergency department visits with time‐varying dependence

Canadian Journal of Statistics, EarlyView.
Abstract Jointly modelling multiple correlated count time series is essential in health services research, where outcomes like emergency visits for mental health and substance use often evolve together. Ignoring these dependencies can obscure meaningful trends and limit the effectiveness of policy evaluation.
Guanjie Lyu, Cindy Feng, Lihui Liu
wiley   +1 more source

An adapted health system access framework for avoidable inflammatory bowel disease admissions: a scoping review. [PDF]

Crohns Colitis 360
Hawkins RL, Butler K, Sampson FC, Lobo AJ, Hind D.   +4 more
europepmc   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source